BNP

B-Type Natriuretic Peptide / NT-proBNP

Q: What is the difference between BNP and NT-proBNP?

Both are released from the same precursor molecule when the heart is stressed. BNP is the biologically active hormone with a 20-minute half-life, while NT-proBNP is the inactive fragment with a 120-minute half-life. They are not interchangeable—their reference ranges and cutoffs differ significantly. NT-proBNP is more affected by age and kidney function, while BNP levels can be lowered by the drug sacubitril (in Entresto), which inhibits BNP breakdown. Your doctor will consistently use one or the other for monitoring.

Q: Can BNP be elevated without heart failure?

Yes. BNP and NT-proBNP can be elevated in atrial fibrillation, pulmonary embolism, pulmonary hypertension, severe sepsis, chronic kidney disease, and advanced age—all of which cause cardiac wall stress without necessarily indicating heart failure. The test is most powerful for ruling out heart failure (high negative predictive value) rather than ruling it in. Clinical context, echocardiography, and other testing are needed to confirm the diagnosis.

Q: Why might BNP be low in obese patients with heart failure?

Adipose tissue expresses natriuretic peptide clearance receptors (NPR-C) that actively remove BNP from the circulation. Consequently, obese patients with genuine heart failure may have BNP levels that are lower than expected for their degree of cardiac dysfunction. Some guidelines suggest using lower BNP cutoffs in obese patients or relying more on NT-proBNP, which is less affected by adiposity. If clinical suspicion for heart failure is high, pursue echocardiography regardless of the BNP level.

Cardíaco

Última revisión: 7 de abril de 2026. Enfoque de fuentes: contexto estándar de interpretación de laboratorio, material médico de referencia y orientación clínica o de salud pública cuando corresponde.

¿Qué es B-Type Natriuretic Peptide / NT-proBNP?

B-type natriuretic peptide (BNP) and its amino-terminal fragment NT-proBNP are cardiac neurohormones released primarily from ventricular cardiomyocytes in response to myocardial wall stress caused by volume overload or pressure overload. When the ventricles are stretched, the precursor molecule proBNP is cleaved into the biologically active BNP (32 amino acids) and the inactive NT-proBNP (76 amino acids). BNP acts on natriuretic peptide receptors to promote vasodilation, natriuresis (sodium excretion in urine), diuresis, and suppression of the renin-angiotensin-aldosterone system and sympathetic nervous system—all of which serve to reduce cardiac workload.

BNP and NT-proBNP are the cornerstone biomarkers for the diagnosis, risk stratification, and management of heart failure. They are particularly valuable in the emergency department for differentiating cardiac from pulmonary causes of acute dyspnea. NT-proBNP has a longer half-life (120 minutes vs. 20 minutes for BNP) and higher circulating concentrations, making it easier to measure, but it is more affected by renal function and age. Both markers have well-established age- and sex-specific cutoffs, and serial measurements are used to guide heart failure therapy and predict outcomes.

Por qué importa

BNP and NT-proBNP are among the most important biomarkers in cardiovascular medicine. A normal BNP or NT-proBNP level has a very high negative predictive value for heart failure—meaning if the level is normal, heart failure is very unlikely as the cause of a patient's symptoms. Elevated levels not only support the diagnosis of heart failure but also correlate with its severity (higher New York Heart Association class corresponds to higher levels). Serial monitoring helps clinicians titrate medications and detect worsening before clinical symptoms appear. These markers also provide prognostic information in acute coronary syndromes, pulmonary embolism, and sepsis.

Rangos de referencia normales

Grupo	Rango	Unidad
BNP: Adults < 75 years	<100	pg/mL
BNP: Adults ≥ 75 years	<200	pg/mL
NT-proBNP: Adults < 75 years	<125	pg/mL
NT-proBNP: Adults ≥ 75 years	<450	pg/mL
NT-proBNP: Heart failure exclusion cutoff (acute dyspnea)	<300	pg/mL

Los rangos de referencia pueden variar entre laboratorios. Compara siempre tus resultados con los rangos proporcionados por tu laboratorio.

Qué significan los niveles altos de BNP

Causas comunes

Heart failure (systolic or diastolic)
Acute coronary syndromes
Pulmonary embolism
Atrial fibrillation or other arrhythmias
Valvular heart disease (aortic stenosis, mitral regurgitation)
Hypertensive crisis
Pulmonary hypertension
Chronic kidney disease (especially NT-proBNP)
Sepsis and critical illness
Cardiac amyloidosis

Posibles síntomas

Shortness of breath (dyspnea), especially on exertion or when lying flat
Swelling of the legs, ankles, or abdomen (edema)
Fatigue and exercise intolerance
Rapid or irregular heartbeat
Persistent cough or wheezing
Weight gain from fluid retention
Difficulty sleeping due to breathlessness (orthopnea, PND)

Qué hacer: Elevated BNP or NT-proBNP in the setting of dyspnea strongly suggests heart failure. Further evaluation should include echocardiography to assess cardiac structure and function, an electrocardiogram, chest X-ray, and renal function tests. Treatment of heart failure follows guideline-directed medical therapy including ACE inhibitors or ARNIs, beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. Serial BNP/NT-proBNP monitoring helps guide therapy intensity and detect clinical deterioration early.

Qué significan los niveles bajos de BNP

Causas comunes

Obesity (BNP is paradoxically lower in obese patients due to increased clearance by adipose tissue natriuretic peptide receptors)
Flash pulmonary edema with very acute onset (BNP may not have risen yet)
Constrictive pericarditis (in some cases)

Posibles síntomas

Low BNP itself does not cause symptoms
A normal or low BNP in the right clinical context is reassuring against heart failure

Qué hacer: Low BNP/NT-proBNP effectively rules out heart failure as the cause of symptoms in most clinical scenarios. In obese patients, be aware that BNP cutoffs may need to be adjusted downward, and a "normal" BNP does not completely exclude heart failure. If clinical suspicion remains high despite low natriuretic peptides, proceed with echocardiography.

¿Cuándo se recomienda la prueba de BNP?

When evaluating acute dyspnea in the emergency department to differentiate cardiac from pulmonary causes
For diagnosis and staging of heart failure
To guide and monitor heart failure treatment (serial measurements)
As a prognostic marker in acute coronary syndromes or pulmonary embolism
When screening high-risk patients for cardiac dysfunction (e.g., before cardiotoxic chemotherapy)

Preguntas frecuentes

Both are released from the same precursor molecule when the heart is stressed. BNP is the biologically active hormone with a 20-minute half-life, while NT-proBNP is the inactive fragment with a 120-minute half-life. They are not interchangeable—their reference ranges and cutoffs differ significantly. NT-proBNP is more affected by age and kidney function, while BNP levels can be lowered by the drug sacubitril (in Entresto), which inhibits BNP breakdown. Your doctor will consistently use one or the other for monitoring.

Yes. BNP and NT-proBNP can be elevated in atrial fibrillation, pulmonary embolism, pulmonary hypertension, severe sepsis, chronic kidney disease, and advanced age—all of which cause cardiac wall stress without necessarily indicating heart failure. The test is most powerful for ruling out heart failure (high negative predictive value) rather than ruling it in. Clinical context, echocardiography, and other testing are needed to confirm the diagnosis.

Adipose tissue expresses natriuretic peptide clearance receptors (NPR-C) that actively remove BNP from the circulation. Consequently, obese patients with genuine heart failure may have BNP levels that are lower than expected for their degree of cardiac dysfunction. Some guidelines suggest using lower BNP cutoffs in obese patients or relying more on NT-proBNP, which is less affected by adiposity. If clinical suspicion for heart failure is high, pursue echocardiography regardless of the BNP level.

Biomarcadores relacionados

cTnTroponina CKCreatine Kinase CrCreatinina D-DDímero D

Referencias y enfoque de revisión

Las páginas del glosario de biomarcadores son explicaciones educativas y deben interpretarse junto con los rangos de referencia y comentarios proporcionados por tu laboratorio y tu profesional de salud. Para conocer nuestros estándares editoriales y proceso de revisión, consulta nuestra Política editorial y nuestro Proceso de revisión de contenido.

¿Quieres analizar tus niveles de BNP?

Sube tus resultados de laboratorio para recibir un análisis instantáneo con IA de todos tus biomarcadores.

Subir resultados de laboratorio →

Aviso médico: Esta información es solo educativa y no sustituye el consejo, diagnóstico ni tratamiento médico profesional. Los rangos de referencia pueden variar entre laboratorios. Consulta siempre a tu profesional sanitario para interpretar tus resultados concretos.